HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Janos Tomcsanyi Selected Research

Natriuretic Peptides

11/2020Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Janos Tomcsanyi Research Topics

Disease

2Heart Failure
01/2021 - 11/2020
1Systolic Heart Failure
01/2021

Drug/Important Bio-Agent (IBA)

2Cardiac MyosinsIBA
01/2021 - 11/2020
2omecamtiv mecarbilIBA
01/2021 - 11/2020
1Brain Natriuretic Peptide (Natrecor)FDA Link
11/2020
1Natriuretic PeptidesIBA
11/2020
1sacubitril and valsartan sodium hydrate drug combinationIBA
11/2020

Therapy/Procedure

2Therapeutics
01/2021 - 11/2020